國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁 到查詢結果 [ subject:"Immunotherapy" ]

切換: 標籤 | MARC模式 | ISBD

Developing costimulatory molecules f...

Mir, Manzoor Ahmad,

Developing costimulatory molecules for immunotherapy of diseases

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Developing costimulatory molecules for immunotherapy of diseasesManzoor Ahmad Mir.
作者:	Mir, Manzoor Ahmad,
出版者:	London :Academic Press is an imprint of Elsevier,©2015.
面頁冊數:	1 online resource :col. ill.
標題:	Immunologic diseasesTreatment.
電子資源:	https://www.sciencedirect.com/science/book/9780128025857
ISBN:	9780128026755 (electronic bk.)

Developing costimulatory molecules for immunotherapy of diseases
Mir, Manzoor Ahmad,

Developing costimulatory molecules for immunotherapy of diseases[electronic resource] /Manzoor Ahmad Mir. - London :Academic Press is an imprint of Elsevier,©2015. - 1 online resource :col. ill.

Includes bibliographical references and index.

Developing Costimulatory Molecules for Immunotherapy of Diseases highlights the novel concept of reverse costimulation and how it can be effectively exploited to develop immunotherapy using either humanized antibodies against CD80, CD86, and other costimulatory molecules or CD28 fusinogenic proteins in the treatment of diseases, including allergies, asthma, rheumatoid arthritis, multiple sclerosis, lupus nephritis, severe psoriasis, vulgaris tuberculosis, thopoid, transplantation therapeutic, cancer, and inflammation. The text aims to provide the latest information on the complex roles an.

ISBN: 9780128026755 (electronic bk.)Subjects--Topical Terms:

867107
Immunologic diseases
--Treatment.Index Terms--Genre/Form:

214472
Electronic books.

LC Class. No.: RM275

Dewey Class. No.: 616.079

National Library of Medicine Call No.: QW 940

Developing costimulatory molecules for immunotherapy of diseases
LDR:01798nmm a2200277 a 4500 001 578371
006 m o d
007 cr cnu|unuuu||
008 201211s2015 enka ob 001 0 eng d
020 $a 9780128026755 (electronic bk.)
020 $a 0128026758 (electronic bk.)
020 $a 9780128025857
020 $a 0128025859
035 $a (OCoLC)910324332
035 $a ELS20100005
040 $a N $b eng $c N $d EBLCP $d N $d CUS $d OPELS $d IDEBK $d YDXCP $d CDX $d OCLCF $d ABH $d OCLCQ $d LVT $d ITD $d OCLCO $d OCLCQ $d OCLCA $d U3W $d OCLCO $d D6H $d AU@ $d OCLCO $d MERER $d OCLCO $d OCLCQ $d CUY $d OCLCQ $d ZCU $d MERUC $d ICG $d USU $d OCLCO $d DKC $d OCLCO $d OCLCQ $d FEM $d OCLCQ $d UHL $d OCLCQ $d UKMGB $d OCLCQ $d E7B $d WYU $d LOA $d K6U $d COCUF $d VT2 $d GZM $d OCLCA $d VLY
041 0 $a eng
050 4 $a RM275
060 4 $a QW 940
082 0 4 $a 616.079 $2 23
100 1 $a Mir, Manzoor Ahmad, $e author. $3 867106
245 1 0 $a Developing costimulatory molecules for immunotherapy of diseases $h [electronic resource] / $c Manzoor Ahmad Mir.
260 $a London : $b Academic Press is an imprint of Elsevier, $c ©2015.
300 $a 1 online resource : $b col. ill.
504 $a Includes bibliographical references and index.
520 $a Developing Costimulatory Molecules for Immunotherapy of Diseases highlights the novel concept of reverse costimulation and how it can be effectively exploited to develop immunotherapy using either humanized antibodies against CD80, CD86, and other costimulatory molecules or CD28 fusinogenic proteins in the treatment of diseases, including allergies, asthma, rheumatoid arthritis, multiple sclerosis, lupus nephritis, severe psoriasis, vulgaris tuberculosis, thopoid, transplantation therapeutic, cancer, and inflammation. The text aims to provide the latest information on the complex roles an.
588 0 $a Online resource; title from PDF title page (Ebsco, viewed June 3, 2015).
650 0 $a Immunologic diseases $x Treatment. $3 867107
650 0 $a Cellular therapy. $3 201246
650 0 $a Immunotherapy. $3 211033
650 1 2 $a Immunotherapy $x methods. $3 340356
650 2 2 $a Antibodies $x metabolism $3 867108
650 2 2 $a B7 Antigens $x metabolism. $3 867109
650 2 2 $a Antigen-Antibody Reactions $x immunology. $3 867110
655 4 $a Electronic books. $2 local. $3 214472
856 4 0 $u https://www.sciencedirect.com/science/book/9780128025857